ASSET PURCHASE AGREEMENTAsset Purchase Agreement • September 28th, 2018 • Arog Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 28th, 2018 Company Industry JurisdictionThis Asset Purchase Agreement (this “Agreement”) is made and entered into effective as of January 5, 2015 (the “Effective Date”), by and between Arog Pharmaceuticals, Inc., a Delaware corporation ( “Seller”), and Videra Pharmaceuticals, LLC a Delaware limited liability company ( “Buyer”). Seller and Buyer are sometimes referred to herein as the “Parties,” and each, a “Party.”
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • September 28th, 2018 • Arog Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 28th, 2018 Company Industry JurisdictionThis Asset Purchase Agreement (this “Agreement”) is made and entered into effective as of January 5, 2015 (the “Effective Date”), by and between Arog Pharmaceuticals, Inc., a Delaware corporation ( “Seller”), and Videra Pharmaceuticals, LLC a Delaware limited liability company ( “Buyer”). Seller and Buyer are sometimes referred to herein as the “Parties,” and each, a “Party.”
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • September 24th, 2018 • Arog Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 24th, 2018 Company Industry JurisdictionThis Asset Purchase Agreement (this “Agreement”) is made and entered into effective as of January 5, 2015 (the “Effective Date”), by and between Arog Pharmaceuticals, Inc., a Delaware corporation ( “Seller”), and Videra Pharmaceuticals, LLC a Delaware limited liability company ( “Buyer”). Seller and Buyer are sometimes referred to herein as the “Parties,” and each, a “Party.”